Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Abbott Laboratories’ Q1 2023 results
Healthcare company Abbott Laboratories (NYSE: ABT) announced financial results for the first quarter of 2023, reporting a decline in net sales and adjusted earnings.
First-quarter net sales dropped 18% year-over-year to $9.75 billion. The decline is primarily due to a decrease in COVID-19 testing-related sales versus the prior year.
Consequently, the company’s adjusted earnings, excluding special items, dropped to $1.03 per share in the latest quarter from $1.73 per share in the same period of last year. Unadjusted net income was $1.32 billion or $0.75 per share, compared to $2.45 billion or $1.37 per share last year.
Prior Performance
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
